StockData
Schrodinger, Inc. logo

Schrodinger, Inc. (SDGR) stock

SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3079% above fair value
$30.85−0.67 (-2.13%)

Close on Nov 12, 2026Market cap $2.31BP/E –Yield –

Schrodinger, Inc. grew revenue 4.8% to $269.20M over the twelve months to Sep 30, 2026. Free cash flow was -$116.77M. At the latest close the market valued the company at $2.31B.

Revenue
$269.20M
+4.8% vs. a year earlier
Operating income
-$133.63M
TTM Q3 2026
Free cash flow
-$116.77M
TTM Q3 2026
EPS, diluted
-$0.79
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$2.31B
P/E ratio
–
Price to sales
8.57
Price to book
7.65
Dividend yield
–
Free cash flow yield
-5.06%

Fundamentals

Revenue
$269.20M
Net income
-$59.25M
EPS, diluted
-$0.79
Free cash flow
-$116.77M
Book value per share
$4.03
Diluted shares
75M

Trading

Next earnings
Feb 24, 2027 (estimated, during market hours)
Previous close
$31.52
Open
$30.30
Day's range
$28.70 – $31.44
Volume
1,359,386
Average volume (20 days)
1,747,372
Index membership
S&P SmallCap 600 (since Aug 2023), Russell 2000 (since Mar 2020), Russell 3000 (since Feb 2020)
Beta (5 years)
1.85
52-week range
$10.95 – $34.00
RSI (14 days)
58.2
Volatility (1 year)
66.7%
Relative volume
0.77×
WACC
14.1%

Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2020, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodSDGRS&P 500DifferenceSDGR per yearS&P 500 per year
1 month+19.1%-2.7%+21.8 pts
3 months+65.6%-1.7%+67.3 pts
Year to date+72.5%+11.9%+60.6 pts
1 year+71.6%+12.0%+59.6 pts
3 years+12.9%+78.2%−65.3 pts+4.1%+21.2%
5 years-34.5%+73.2%−107.8 pts-8.1%+11.6%

Eight years at a glance

Fiscal years 2018 to 2025 and trailing twelve months, USD

Revenue

$269.20M+4.8% YoY

Gross profit

$157.53M+5.4% YoY

Operating income

-$133.63M

Net income

-$59.25M

EPS, diluted

-$0.79

Free cash flow

-$116.77M
Reported periodTrailing twelve months

Press releases

Releases Schrodinger filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Schrodinger

Pharmaceutical Preparations

Schrödinger, Inc. provides a physics-based computational software platform used to discover and design molecules for therapeutic and materials science applications. The company operates primarily through software licensing and collaborative and proprietary drug discovery programs. Its software products, including Glide, FEP+, and the LiveDesign enterprise informatics platform, assist biopharmaceutical and industrial companies, academic institutions, and government laboratories in modeling molecular interactions, optimizing candidates, and conducting lead optimization. In materials science, Schrödinger offers solutions across organic electronics, semiconductors, aerospace, energy, and chemicals.

Company profile, executives and history

Schrodinger stock: common questions

What is Schrodinger's stock price?

SDGR closed at $30.85 on Nov 12, 2026, down 2.13% on the day. Over the past 52 weeks it traded between $10.95 and $34.00.

What is Schrodinger's market cap?

Schrodinger was worth $2.31B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is SDGR's P/E ratio?

Schrodinger lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.79), so it has no meaningful P/E ratio.

How much revenue does Schrodinger make?

Schrodinger reported revenue of $269.20M for the twelve months to Sep 30, 2026, up 4.8% from a year earlier.

Does Schrodinger pay a dividend?

No. Schrodinger has not paid a cash dividend over the last twelve months.

When does Schrodinger report earnings next?

Schrodinger is expected to report Q4 FY2026 results on Feb 24, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has SDGR stock performed over the past year?

Including dividends, SDGR returned +71.6% over the past year, against +12.0% for the S&P 500.

How many SDGR shares are sold short?

10M shares were sold short at the latest FINRA report, 13.47% of the float, or 5.8 days of average trading volume.

Who are Schrodinger's competitors?

Companies most similar to Schrodinger by business, industry and size include LGND, EVO, MRVI, AAPG, ARVN.

See a number that looks wrong?